Ivanova JI - Search Results

1

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T. Kirson NY, et al. Among authors: ivanova ji. Appl Health Econ Health Policy. 2011 Sep 1;9(5):293-303. doi: 10.2165/11592430-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21875160

2

Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D. Wu EQ, et al. Among authors: ivanova ji. J Manag Care Pharm. 2007 Sep;13(7):561-9. doi: 10.18553/jmcp.2007.13.7.561. J Manag Care Pharm. 2007. PMID: 17874862 Free PMC article.

3

Costs and resource use of mild persistent asthma patients initiated on controller therapy.

Colice GL, Yu AP, Ivanova JI, Hsieh M, Birnbaum HG, Lage MJ, Brewster C. Colice GL, et al. Among authors: ivanova ji. J Asthma. 2008 May;45(4):293-9. doi: 10.1080/02770900801911178. J Asthma. 2008. PMID: 18446593

4

Adherence to inhaled corticosteroid use and local adverse events in persistent asthma.

Ivanova JI, Birnbaum HG, Hsieh M, Yu AP, Seal B, van der Molen T, Emani S, Rosiello RA, Colice GL. Ivanova JI, et al. Am J Manag Care. 2008 Dec;14(12):801-9. Am J Manag Care. 2008. PMID: 19067497 Free article.

5

Asthma severity categorization using a claims-based algorithm or pulmonary function testing.

Birnbaum HG, Ivanova JI, Yu AP, Hsieh M, Seal B, Emani S, Rosiello R, Colice GL. Birnbaum HG, et al. Among authors: ivanova ji. J Asthma. 2009 Feb;46(1):67-72. doi: 10.1080/02770900802503099. J Asthma. 2009. PMID: 19191141

6

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.

Birnbaum HG, Ivanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, Meletiche D. Birnbaum HG, et al. Among authors: ivanova ji. Curr Med Res Opin. 2009 Apr;25(4):869-77. doi: 10.1185/03007990902743869. Curr Med Res Opin. 2009. PMID: 19232041

7

The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D. Ivanova JI, et al. Pharmacoeconomics. 2009;27(8):681-91. doi: 10.2165/11314700-000000000-00000. Pharmacoeconomics. 2009. PMID: 19712010

8

Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population.

Simpson RJ Jr, Signorovitch J, Birnbaum H, Ivanova J, Connolly C, Kidolezi Y, Kuznik A. Simpson RJ Jr, et al. Mayo Clin Proc. 2009 Dec;84(12):1065-72. doi: 10.4065/mcp.2009.0298. Mayo Clin Proc. 2009. PMID: 19955243 Free PMC article.

9

Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.

Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S. Ivanova JI, et al. Epilepsia. 2010 May;51(5):838-44. doi: 10.1111/j.1528-1167.2009.02422.x. Epub 2009 Dec 7. Epilepsia. 2010. PMID: 20002150 Free article.

10

Economic burden of epilepsy among the privately insured in the US.

Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S. Ivanova JI, et al. Pharmacoeconomics. 2010;28(8):675-85. doi: 10.2165/11535570-000000000-00000. Pharmacoeconomics. 2010. PMID: 20623993

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters